Compile Data Set for Download or QSAR
Report error Found 106 Enz. Inhib. hit(s) with all data for entry = 9371
TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM461847(3,4-Dichlorophenyl 3-deoxy-3-[4-(2,3,4,5,6-pentafl...)
Affinity DataKd:  2nMAssay Description:The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/25/2021
Entry Details
US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM461829(3,4-Dichlorophenyl 3-deoxy-3-[4-(3,4,5-trifluoroph...)
Affinity DataKd:  10nMAssay Description:The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/25/2021
Entry Details
US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM461858(3,4-Dichlorophenyl 3-deoxy-3-[4-(2,3,4,5,6-pentafl...)
Affinity DataKd:  13nMAssay Description:The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/25/2021
Entry Details
US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM461814(3,4-Dichlorophenyl 3-deoxy-3-[4-(3,4,5-triflooroph...)
Affinity DataKd:  17nMAssay Description:The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/25/2021
Entry Details
US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM461863(3,5-Dichloro-4-fluorophenyl 3-deoxy-3-[4-(3,4,5-tr...)
Affinity DataKd:  18nMAssay Description:The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/25/2021
Entry Details
US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM461854(5-Bromo-6-trifluoromethyl-pyridin-3-yl 3-deoxy-3-[...)
Affinity DataKd:  23nMAssay Description:The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/25/2021
Entry Details
US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM461849(5-Bromopyridin-3-yl 3-deoxy-3-[4-(3,4,5-trifluorop...)
Affinity DataKd:  23nMAssay Description:The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/25/2021
Entry Details
US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM461844(3-Bromophenyl 3-deoxy-3-[4-(3,4,5-trifluorophenyl)...)
Affinity DataKd:  23nMAssay Description:The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/25/2021
Entry Details
US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM461865(3-Bromo-4-fluorophenyl 3-deoxy-3-[4-(3,4,5-trifluo...)
Affinity DataKd:  24nMAssay Description:The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/25/2021
Entry Details
US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM461909(5-Chloro-6-trifluoromethyl-pyridine-3-yl 3-deoxy-3...)
Affinity DataKd:  26nMAssay Description:The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/25/2021
Entry Details
US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM461864(3,4-Dichloro-6-fluorophenyl 3-deoxy-3-[4-(3,4,5-tr...)
Affinity DataKd:  27nMAssay Description:The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/25/2021
Entry Details
US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM461895(5-Bromopyridin-3-yl 3-deoxy-3-[4-(3,4,5-trifluorop...)
Affinity DataKd:  28nMAssay Description:The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/25/2021
Entry Details
US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM461852(3-Chloro-6-fluoro-4-cyanophenyl 3-deoxy-3-[4-(3,4,...)
Affinity DataKd:  29nMAssay Description:The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/25/2021
Entry Details
US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM461866(3-Chloro-4-(trifluoromethyl)phenyl 3-deoxy-1-thio-...)
Affinity DataKd:  31nMAssay Description:The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/25/2021
Entry Details
US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM461851(3-Chloro-4-cyanophenyl 3-deoxy-3-[4-(3,4,5-trifluo...)
Affinity DataKd:  31nMAssay Description:The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/25/2021
Entry Details
US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM461898(5-Bromopyridin-3-yl 3-deoxy-3-[4-(3,4,5-trifluorop...)
Affinity DataKd:  31nMAssay Description:The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/25/2021
Entry Details
US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM461867(3,4,5-Trichlorophenyl 3-deoxy-1-thio-3-[4-(3,4,5-t...)
Affinity DataKd:  34nMAssay Description:The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/25/2021
Entry Details
US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM461848(5-Chloropyridin-3-yl 3-deoxy-3-[4-(3,4,5-trifluoro...)
Affinity DataKd:  35nMAssay Description:The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/25/2021
Entry Details
US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM461857(3,4-Dichlorophenyl 3-deoxy-1-thio-3-[4-(2,3,4,5,6-...)
Affinity DataKd:  37nMAssay Description:The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/25/2021
Entry Details
US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM461807(3-Bromophenyl 3-deoxy-3-[4-(3,4,5-trifluorophenyl)...)
Affinity DataKd:  37nMAssay Description:The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/25/2021
Entry Details
US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM461855(5-Chloro-6-cyano-pyridin-3-yl 3-deoxy-3-[4-(3,4,5-...)
Affinity DataKd:  39nMAssay Description:The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/25/2021
Entry Details
US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM461850(3-Chloro-5-cyanophenyl 3-deoxy-3-[4-(3,4,5-trifluo...)
Affinity DataKd:  41nMAssay Description:The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/25/2021
Entry Details
US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM461900(5-Chloropyridin-3-yl 3-deoxy-3-[4-(3,4,5-trifluoro...)
Affinity DataKd:  41nMAssay Description:The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/25/2021
Entry Details
US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM461853(3-Bromo-4-cyanophenyl 3-deoxy-3-[4-(3,4,5-trifluor...)
Affinity DataKd:  43nMAssay Description:The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/25/2021
Entry Details
US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM461868(5-Chloro-2-fluorophenyl 3-deoxy-1-thio-3-[4-(3,4,5...)
Affinity DataKd:  46nMAssay Description:The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/25/2021
Entry Details
US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM461869(5-Bromo-2-fluorophenyl 3-deoxy-1-thio-3-[4-(3,4,5-...)
Affinity DataKd:  47nMAssay Description:The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/25/2021
Entry Details
US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM461907(5-Bromopyridin-3-yl 3-deoxy-3-[4-(3,4-difluorophen...)
Affinity DataKd:  47nMAssay Description:The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/25/2021
Entry Details
US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM461833(3-Chloro-4-fluorophenyl 3-deoxy-3-[4-(3,4,5-triflu...)
Affinity DataKd:  48nMAssay Description:The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/25/2021
Entry Details
US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM461824(3-Chlorophenyl 3-deoxy-3-[4-(3,4,5-trifluorophenyl...)
Affinity DataKd:  49nMAssay Description:The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/25/2021
Entry Details
US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM461856(5-Chloro-6-cyano-pyridazin-3-yl 3-deoxy-3-[4-(3,4,...)
Affinity DataKd:  54nMAssay Description:The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/25/2021
Entry Details
US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM461841(2,4,5-Trichlorophenyl 3-deoxy-3-[4-(3,4,5-trifluor...)
Affinity DataKd:  60nMAssay Description:The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/25/2021
Entry Details
US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM461830(3,4-Dichlorophenyl 3-deoxy-3-[4-(3,4,5-trifluoroph...)
Affinity DataKd:  62nMAssay Description:The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/25/2021
Entry Details
US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM461911(5-Chloro-6-cyano-pyridine-3-yl 3-deoxy-3-[4-(3,4-d...)
Affinity DataKd:  74nMAssay Description:The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/25/2021
Entry Details
US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM461821(3,5-Dichlorophenyl 3-deoxy-3-[4-(3,4,5-trifluoroph...)
Affinity DataKd:  80nMAssay Description:The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/25/2021
Entry Details
US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM461912(3-Chloro-4-cyanophenyl 3-deoxy-3-[4-(3,4-difluorop...)
Affinity DataKd:  83nMAssay Description:The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/25/2021
Entry Details
US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM461870(5-Chloro-2-methoxyphenyl 3-deoxy-1-thio-3-[4-(3,4,...)
Affinity DataKd:  84nMAssay Description:The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/25/2021
Entry Details
US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM461842(2,5-Dichlorophenyl 3-deoxy-3-[4-(3,4,5-trifluoroph...)
Affinity DataKd:  84nMAssay Description:The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/25/2021
Entry Details
US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM461871(3-Iodophenyl 3-deoxy-1-thio-3-[4-(3,4,5-trifluorop...)
Affinity DataKd:  90nMAssay Description:The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/25/2021
Entry Details
US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM461910(5-Chloro-2-trifluoromethyl-pyridine-3-yl 3-deoxy-3...)
Affinity DataKd:  93nMAssay Description:The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/25/2021
Entry Details
US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM461906(5-Chloropyridin-3-yl 3-deoxy-3-[4-(3,4-difluorophe...)
Affinity DataKd:  100nMAssay Description:The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/25/2021
Entry Details
US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM461899(5-Chloropyridin-3-yl 3-deoxy-3-[4-(3,4,5-trifluoro...)
Affinity DataKd:  106nMAssay Description:The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/25/2021
Entry Details
US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM461878(3,4-Dichlorophenyl 3-deoxy-3-[4-(3,4-difluoropheny...)
Affinity DataKd:  110nMAssay Description:The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/25/2021
Entry Details
US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM461879(3,4-Dichlorophenyl 3-deoxy-3-[4-(3,4-difluoropheny...)
Affinity DataKd:  110nMAssay Description:The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/25/2021
Entry Details
US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM461819(3-(Trifluoromethyl)phenyl 3-deoxy-3-[4-(3,4,5-trif...)
Affinity DataKd:  130nMAssay Description:The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/25/2021
Entry Details
US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM461897(5-Bromopyridin-3-yl 3-deoxy-3-[4-(3,4,5-trifluorop...)
Affinity DataKd:  130nMAssay Description:The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/25/2021
Entry Details
US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM461880(3,4-Dichlorophenyl 3-deoxy-3-[4-(3-fluorophenyl)-1...)
Affinity DataKd:  140nMAssay Description:The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/25/2021
Entry Details
US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM461806(3,4-Dimethylphenyl 3-deoxy-3-[4-(3,4,5-triflooroph...)
Affinity DataKd:  150nMAssay Description:The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/25/2021
Entry Details
US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM461861(3-Chloro-2,4-difluorophenyl 3-deoxy-1-thio-3-[4-(3...)
Affinity DataKd:  150nMAssay Description:The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/25/2021
Entry Details
US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM461872(Picolinamide-5-yl 3-deoxy-3-[4-(3,4,5-trifluorophe...)
Affinity DataKd:  180nMAssay Description:The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/25/2021
Entry Details
US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM461817(2-Naphtyl 3-deoxy-3-[4-(3,4,5-trifluorophenyl)-1H-...)
Affinity DataKd:  180nMAssay Description:The affinity of Example 1-106 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/25/2021
Entry Details
US Patent

Displayed 1 to 50 (of 106 total ) | Next | Last >>
Jump to: